- Home
- PRAX vs DDI Comparison
PRAX vs DDI Comparison
Compare PRAX & DDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- DDI
- Stock Information
- Founded
- PRAX 2015
- DDI 2008
- Country
- PRAX United States
- DDI South Korea
- Employees
- PRAX N/A
- DDI N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- DDI EDP Services
- Sector
- PRAX Health Care
- DDI Technology
- Exchange
- PRAX Nasdaq
- DDI Nasdaq
- Market Cap
- PRAX 599.7M
- DDI 489.1M
- IPO Year
- PRAX 2020
- DDI 2021
- Fundamental
- Price
- PRAX $38.35
- DDI $10.96
- Analyst Decision
- PRAX Strong Buy
- DDI Strong Buy
- Analyst Count
- PRAX 10
- DDI 4
- Target Price
- PRAX $116.50
- DDI $21.50
- AVG Volume (30 Days)
- PRAX 430.8K
- DDI 27.5K
- Earning Date
- PRAX 05-02-2025
- DDI 05-13-2025
- Dividend Yield
- PRAX N/A
- DDI N/A
- EPS Growth
- PRAX N/A
- DDI 27.20
- EPS
- PRAX N/A
- DDI 2.31
- Revenue
- PRAX $8,122,000.00
- DDI $315,157,843.00
- Revenue This Year
- PRAX N/A
- DDI N/A
- Revenue Next Year
- PRAX $789.73
- DDI $2.43
- P/E Ratio
- PRAX N/A
- DDI $4.75
- Revenue Growth
- PRAX 270.02
- DDI 15.47
- 52 Week Low
- PRAX $26.70
- DDI $8.88
- 52 Week High
- PRAX $91.83
- DDI $18.21
- Technical
- Relative Strength Index (RSI)
- PRAX 53.31
- DDI 68.38
- Support Level
- PRAX $34.89
- DDI $9.40
- Resistance Level
- PRAX $40.89
- DDI $10.45
- Average True Range (ATR)
- PRAX 2.30
- DDI 0.54
- MACD
- PRAX 0.70
- DDI 0.13
- Stochastic Oscillator
- PRAX 57.95
- DDI 85.57
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About DDI DoubleDown Interactive Co. Ltd. American Depository Shares
DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. Its market opportunity includes casual gaming globally, which includes slots, puzzles, cards, match three, and other similar games. Within the social casino segment of casual gaming, which includes free-to-play online slots, poker, table games, and bingo. Other games developed by the company are DoubleDown Fort, DoubleDown Classic, and Ellen's Road to Riches. The company has a presence in the international market, and it derives a majority of its revenue from the United States of America.